CTOs on the Move

Southwest Health Systems

www.smrmc.com

 
Southwest Mississippi Regional Medical Center (SMRMC) in McComb, Mississippi was established in 1969, and serves a seven-county area of Mississippi. SMRMC also draws from two parishes in neighboring eastern Louisiana. According to the most recent
  • Number of Employees: 250-1000
  • Annual Revenue: $250-500 Million
  • www.smrmc.com
  • 215 Marion Ave
    Mccomb, MS USA 39648
  • Phone: 601.249.5500

Executives

Name Title Contact Details

Similar Companies

VisionShare Inc

VisionShare Inc is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

St. Peter's Health Care Services

St. Peter's Health Care Services is a Albany, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

New Mexico Cancer Care

New Mexico Cancer Care is a Santa Fe, NM-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Atlantic Research Group

We are fundamentally dedicated to biopharmaceutical innovators Building a company with this unique mission requires a different philosophy. Which is why Atlantic Research Group's founders built the company on responsive and flexible points of view.

Synthetic Biologics

Synthetic Biologics, Inc. trades on the NYSE MKT, LLC under the symbol "SYN". The Company`s principal executive offices are located in Rockville, MD, and the finance and administrative office is located in Ann Arbor, MI. Synthetic Biologics, Inc. is a microbiome-focused, clinical-stage company developing therapeutics to protect the microbiome while targeting pathogen-specific diseases. The Company`s lead candidates in Phase 2 development include SYN-004 which is designed to protect the gut microbiome from the effects of certain commonly used intravenous (IV) antibiotics for the prevention of C. difficile infection and antibiotic-associated diarrhea (AAD), and SYN-010 which is intended to reduce the impact of methane producing organisms in the gut microbiome to treat the underlying cause of irritable bowel syndrome with constipation (IBS-C). In addition, the Company is developing a monoclonal antibody combination for the treatment of Pertussis, and a Phase 2 oral estriol drug for the treatment of relapsing-remitting multiple sclerosis (MS) and cognitive dysfunction in MS.